朴雪品牌怎么样 申请店铺

我要投票 朴雪在补铁锌硒行业中的票数:8 更新时间:2024-11-21
朴雪是哪个国家的品牌?「朴雪」是 哈药集团有限公司 旗下著名品牌。该品牌发源于黑龙江,由创始人徐志越在1989期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
朴雪怎么样

朴雪为哈药集团制药六厂旗下保健食品品牌,主要产品为朴雪乳酸亚铁口服液,适用于营养性贫血者,能有效改善营养性贫血。

哈药六厂是以生产化学药品及中成药为主,保健食品和"纯中纯"无菌纯净水系列、茶饮料系列为辅的综合制药企业,制剂手段完备,设备先进,可生产大容量注射剂、口服液、糖浆剂、片剂、胶囊剂、颗粒剂和原料药等,产品远销全国。主导产品:盖中盖系列保健食品、严迪、泻痢停、为消、护彤、丹王颗粒等畅销产品。1999年企业开始跨入保健食品生产企业行列。

哈药集团制药六厂(以下简称为“哈药六厂”)始建于1977年,1995年改制为国有控股的股份制企业,2006年改制为国有控股、中外合资企业,是以生产化学药品为主、以保健食品和饮品为辅的综合性企业。

建厂以后,企业长期处于低速发展状态,由于连年亏损,已濒临破产的边缘。1988年以后,全厂职工在调整后的厂级领导班子的正确领导下,团结协作,艰苦奋斗,在短短的二十多年的时间里使企业产生了裂变式的、超常规的发展,取得了令人瞩目的成绩,现已成为省、市政府的纳税大户和哈药集团的四大骨干企业之一,连续多年完成集团公司下达的各项经济技术指标。厂区占地为10万平方米,建筑面积达25万平方米。

企业生产设备先进完善,按照GMP标准要求,全面系统地改造了综合制剂生产车间、固体制剂生产车间及饮品综合生产车间,并全面通过GMP认证和相关验收。

药品生产剂型包括:原料药(人工牛黄)、片剂、胶囊剂、颗粒剂、口服液、糖浆剂、口服溶液剂、合剂(含中药提取);橡胶膏剂、膏药、软胶囊剂和巴布剂12个剂型170余种产品。

保健食品生产包括片剂、口服液两个剂型14种产品。

饮品生产包括饮用纯净水、茶饮料、果汁系列等11种产品。

主导产品有严迪牌罗红霉素分散片、护彤牌小儿氨酚黄那敏颗粒、泻利停牌颠茄磺苄啶片、为消牌乳酸菌素片、新盖中盖牌高钙片、哈药六牌钙加锌口服液、朴雪乳酸亚铁口服液、新盖中盖牌乳酸钙口服液及纯中纯系列饮品等。

Park snow is a brand of health food under the sixth pharmaceutical factory of Harbin Pharmaceutical Group. Its main product is park snow ferrous lactate oral liquid, which is suitable for the patients with nutritional anemia and can effectively improve nutritional anemia. Harbin No.6 Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise mainly engaged in the production of chemicals and Chinese patent medicines, supplemented by health food and "pure and medium" aseptic pure water series and tea beverage series. With complete preparation means and advanced equipment, it can produce large volume injections, oral liquids, syrups, tablets, capsules, granules and APIs. Its products are sold all over the country. Leading products: gaizhonggai series of health food, Yandi, XIELITING, Weixiao, Hutong, Danwang granules and other best-selling products. In 1999, enterprises began to enter the ranks of health food production enterprises. Harbin Pharmaceutical Group Pharmaceutical No.6 factory (hereinafter referred to as "Harbin Pharmaceutical No.6 factory") was founded in 1977, restructured into a state-owned holding joint-stock enterprise in 1995 and a state-owned holding and Sino foreign joint venture in 2006. It is a comprehensive enterprise mainly engaged in the production of chemicals, supplemented by health food and drinks. After the establishment of the factory, the enterprise has been in a state of low-speed development for a long time. Because of years of losses, it is on the verge of bankruptcy. After 1988, under the correct leadership of the adjusted leading group at the factory level, the employees of the whole plant united and cooperated with each other and worked hard. In a short period of more than 20 years, the enterprise had a fission and unconventional development, and made remarkable achievements. Now it has become one of the four backbone enterprises of the provincial and municipal governments and Harbin Pharmaceutical Group, and has completed the group's corporate governance for many years in a row Economic and technical indicators issued by the division. The factory covers an area of 100000 square meters, with a building area of 250000 square meters. The production equipment of the enterprise is advanced and perfect. According to the requirements of GMP standard, the comprehensive preparation production workshop, solid preparation production workshop and beverage comprehensive production workshop have been comprehensively and systematically reformed, and have passed GMP certification and relevant acceptance. Drug production dosage forms include: raw material drug (artificial bezoar), tablet, capsule, granule, oral liquid, syrup, oral solution, mixture (including extraction of traditional Chinese Medicine); rubber plaster, plaster, soft capsule and cataplasm 12 dosage forms of 170 kinds of products. The production of health food includes 14 kinds of products in two dosage forms: tablet and oral liquid. The beverage production includes 11 kinds of products such as drinking pure water, tea beverage, juice series, etc. The main products are Yandi brand roxithromycin dispersible tablets, Houtong brand Xiaoer aminophenol huangnamin granules, XIELITING brand belladonna sulfonylbenzylidine tablets, Weixiao brand Lactobacillin tablets, xingaizhonggai brand high calcium tablets, Harbin medicine Liupai calcium and zinc oral liquid, Puxue ferrous lactate oral liquid, xingaizhonggai brand calcium lactate oral liquid and pure medium pure series drinks, etc.

本文链接: https://brand.waitui.com/43a43fa04.html 联系电话:0451-51961111

千城特选小程序码

7×24h 快讯

拼多多:第三季度营收增速环比下降,将坚定高质量发展战略应对竞争挑战

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多营收达到994亿元,与上个季度相比,营收的增速有所放缓。业内分析认为,一方面是因为电商行业的竞争依然激烈,另一方面是平台的“百亿减免”等举措影响了短期的财报表现。“为了应对行业竞争,我们将坚定地执行高质量发展战略,继续实行‘减免+扶持’的举措,持续完善平台及产业生态,为供需两侧带来更大的普惠。”拼多多陈磊表示。

21分钟前

拼多多:第三季度利润环比下降22%,将长期投入“新质供给”“电商西进”战略

36氪获悉,拼多多发布2024年第三季度财报。财报显示,本季度拼多多利润达到250亿元,环比下降22%。过去这个季度,拼多多先后推出“百亿减免”“电商西进”“新质商家扶持计划”等重磅举措,持续扩大对生态建设的投资,一定程度上影响了短期的财报表现。拼多多陈磊表示,在财务数据之外,我们更加看重生态投资带来的长期价值,未来几个季度,拼多多将继续投入“新质供给”“电商西进”等战略,给用户、商家及产业带来更长远的回报。

21分钟前

莎普爱思:股东拟合计减持不超5%公司股份

36氪获悉,莎普爱思公告,股东陈德康持有公司12.39%股份,上海景兴实业投资有限公司持有公司4.7%股份。陈德康计划减持公司股份数量合计不超过758.32万股,即不超过公司总股本的2%。上海景兴计划减持公司股份数量合计不超过1137.48万股,即不超过公司总股本的3%。

21分钟前

永杰新材上交所主板IPO申请获证监会同意注册批复

36氪获悉,证监会下发关于同意永杰新材料股份有限公司首次公开发行股票注册的批复,同意该公司首次公开发行股票的注册申请。根据招股书,该公司拟在上交所主板上市,公司专业从事铝板带箔的研发、生产与销售,产品主要包括铝板带和铝箔两大类。

21分钟前

东方电缆:公司及子公司近期中标合计约40亿元海底电缆项目

36氪获悉,东方电缆公告,公司及全资子公司东方海工院近期收到相关通知书,确认公司及东方海工院联合体为相关项目中标人。其中,直流海底电缆项目中标金额约15.14亿元,交流海底电缆项目中标金额合计约24.72亿元,以上项目合计中标金额约40亿元。同日公告,公司拟以自有资金投资建设东方中央研究院·总部项目,项目总投资金额约为5.54亿元。

21分钟前

本页详细列出关于凯贝尔的品牌信息,含品牌所属公司介绍,凯贝尔所处行业的品牌地位及优势。
咨询